Clinical utility of the risperidone formulations in the management of schizophrenia
Vishal Madaan1, Durga P Bestha2, Venkata Kolli2, Saurabh Jauhari2, Roger C Burket1 1University of Virginia Health System, Charlottesville, VA, USA; 2Creighton University Medical Center, Omaha, NE, USA Abstract: Risperidone is one of the early second-generation antipsychotics that came into the limel...
Enregistré dans:
Auteurs principaux: | Madaan V, Bestha DP, Kolli VB, Jauhari S, Burket RC |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4e22fb417ecc4272945dff6c78e223b5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Update on optimal use of lisdexamfetamine in the treatment of ADHD
par: Madaan V, et autres
Publié: (2013) -
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
par: Hong Liu-Seifert, et autres
Publié: (2009) -
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
par: Jeffrey R Bishop, et autres
Publié: (2008) -
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
par: Alphs L, et autres
Publié: (2013) -
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
par: Louzã M, et autres
Publié: (2011)